666

GUIZHOU YIBAI PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪3.35 B‬CNY
−0.57CNY
‪−426.47 M‬CNY
‪2.70 B‬CNY
‪606.21 M‬
Beta (1Y)
0.92

About GUIZHOU YIBAI PHARMACEUTICAL

CEO
Ya Qi Dou
Headquarters
Guiyang
Website
Employees (FY)
‪5.56 K‬
Founded
1995
ISIN
CNE000001H03
FIGI
BBG000K85JN7
Guizhou Yibai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include rheumatic bone disease medication, respiratory system medication, cardiovascular and cerebrovascular drugs and other drugs. The company was founded by Dou Qiling on June 12, 1995 and is headquartered in Guiyang, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600594 is 3.82 CNY — it has decreased by 7.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GUIZHOU YIBAI PHARMACEUTICAL stocks are traded under the ticker 600594.
GUIZHOU YIBAI PHARMACEUTICAL is going to release the next earnings report on Apr 19, 2024. Keep track of upcoming events with our Earnings Calendar.
600594 stock is 8.95% volatile and has beta coefficient of 0.92. Check out the list of the most volatile stocks — is GUIZHOU YIBAI PHARMACEUTICAL there?
Yes, you can track GUIZHOU YIBAI PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
600594 stock has fallen by 20.58% compared to the previous week, the month change is a 20.91% fall, over the last year GUIZHOU YIBAI PHARMACEUTICAL has showed a 34.48% decrease.
600594 net income for the last quarter is ‪41.96 M‬ CNY, while the quarter before that showed ‪83.91 M‬ CNY of net income which accounts for −49.99% change. Track more GUIZHOU YIBAI PHARMACEUTICAL financial stats to get the full picture.
Today GUIZHOU YIBAI PHARMACEUTICAL has the market capitalization of ‪3.35 B‬, it has decreased by 1.44% over the last week.
Like other stocks, 600594 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUIZHOU YIBAI PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
600594 reached its all-time high on Jun 15, 2015 with the price of 37.67 CNY, and its all-time low was 1.17 CNY and was reached on Nov 20, 2006.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪5.56 K‬ employees. See our rating of the largest employees — is GUIZHOU YIBAI PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUIZHOU YIBAI PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUIZHOU YIBAI PHARMACEUTICAL stock shows the strong sell signal. See more of GUIZHOU YIBAI PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.